Baltimore’s court case against drug distributors McKesson and AmerisourceBergen centers on a proposed 15-year, $472 million annual plan to combat the city’s opioid epidemic through medication-assisted treatment and harm reduction […]
Economist breaks down Baltimore’s $5 billion opioid crisis plan
